Menu

Takeda Pharmaceutical Company Limited TAK

Full chart Compare
Set alert

Price alert · TAK

All alert types
21.09 USD +0.07 (+0.33%)

At closeNov 9, 2026, 7:17 PM EST

20.85 -0.24 -1.14%

After hours · Nov 9, 7:17 PM ET

20.91 Day range 21.22
13.66 52-week range 21.19
YTD
+35.28%
1 year
+54.39%

Revenue & Expenses

Other Income → Expenses: $208.74BExpenses → Selling, General & Admin: $1.08TExpenses → Research & Development: $675.92BExpenses → Other Operating Expenses: $1.17TExpenses → Interest Expense: $357.57BExpenses → Income Tax: $9.77BGross Profit → Expenses: $2.93TRevenue → Gross Profit: $2.93TRevenue → Cost of Revenue: $1.57TNet Loss → Expenses: $152.39BOther Income$208.74BGross Profit$2.93TNet Loss$152.39BCost of Revenue$1.57TExpenses$3.30TSelling, General & Admin$1.08TResearch & Development$675.92BOther Operating Expenses$1.17TInterest Expense$357.57BIncome Tax$9.77BRevenue$4.51T

Latest period ending Mar 31, 2026 · select a line to chart its full history

Annual income statement

TAK annual income statement
Fiscal yearFY 2026 Mar 31, 2026FY 2025 Mar 31, 2025FY 2024 Mar 31, 2024FY 2023 Mar 31, 2023FY 2022 Mar 31, 2022
4.51T4.58T4.26T4.03T3.57T
28.41B30.69B28.16B30.42B29.31B
1.57T1.58T1.43T1.24T1.11T
2.93T3.00T2.84T2.78T2.46T
2.93T2.66T2.62T2.29T2.00T
675.92B730.23B729.92B633.33B526.09B
1.08T1.10T1.05T997.31B886.36B
6.22B342.59B214.08B490.51B460.85B
357.57B210.06B219.85B169.70B166.61B
9.77B66.94B-91.41B58.05B72.41B
-152.39B107.93B144.07B317.02B230.06B
-152.39B107.93B144.07B317.02B230.06B
-960.97M722.89M951.57M2.39B1.89B
-152.13B108.14B144.20B317.04B230.17B
264.00M215.00M130.00M21.00M107.00M
-48.3834.1846.05102.1573.57
-0.3050.2290.3040.7710.604
-48.3833.6245.58100.9772.94
0.3220.6650.6110.640.727
214.95B384.93B272.51B544.77B469.07B
1.36B2.58B1.80B4.11B3.85B
1.58B1.59B1.57B1.55B1.56B